Litcius/Paper detail

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry

Frank Cools, D. Johnson, Alan John Camm, Jean‐Pierre Bassand, Freek W.A. Verheugt, Shu Yang, Anastasios A. Tsiatis, David Fitzmaurice, Samuel Z. Goldhaber, Gloria Kayani, Shinya Goto, Sylvia Haas, Frank Misselwitz, Alexander G.G. Turpie, Keith A.A. Fox, Karen S. Pieper, Ajay K. Kakkar

2021Journal of Thrombosis and Haemostasis49 citationsDOIOpen Access PDF

Topics & Concepts

DiscontinuationMedicineAtrial fibrillationInternal medicineStroke (engine)Hazard ratioMyocardial infarctionWarfarinLower riskRivaroxabanCardiologySurgeryConfidence intervalMechanical engineeringEngineeringAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementIntracerebral and Subarachnoid Hemorrhage Research
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry | Litcius